Envestnet Asset Management Portfolio holdings
Envestnet Asset Management, a subsidiary of Envestnet, Inc., founded in 1999 by Jud Bergman and Bill Crager, is a Chicago-based financial technology firm that provides wealth management solutions and software to financial advisors and institutions, managing over $426 billion in discretionary assets as of late 2024. Headquartered at 35 East Wacker Drive, it serves a vast network, including over 111,000 advisors and major U.S. banks, with a platform overseeing more than $6.5 trillion in assets, offering tools like portfolio management, trading, and reporting through an integrated ecosystem. Known for its innovative AdvisorSuite software and Portfolio Management Consultants (PMC) division, Envestnet supports advisors with sub-advisory services, research, and data analytics, bolstered by its 2015 acquisition of Yodlee for enhanced data aggregation. Recently acquired by a Bain Capital-led consortium for $4.5 billion in November 2024, Envestnet continues to evolve as a private entity, focusing on scalable, tech-driven wealth management solutions.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BlackRock US Equity Factor Rotation ETF
DYNF
|
+$2.39B |
| 2 |
iShares Core Universal USD Bond ETF
IUSB
|
+$1.55B |
| 3 |
iShares S&P 500 Value ETF
IVE
|
+$1.36B |
| 4 |
iShares S&P 500 Growth ETF
IVW
|
+$948M |
| 5 |
iShares Currency Hedged MSCI EAFE ETF
HEFA
|
+$706M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.01B |
| 2 |
iShares Treasury Floating Rate Bond ETF
TFLO
|
+$1.3B |
| 3 |
iShares ESG Aware MSCI USA ETF
ESGU
|
+$883M |
| 4 |
iShares S&P 100 ETF
OEF
|
+$788M |
| 5 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
+$734M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.07% |
| 2 | Financials | 5.49% |
| 3 | Healthcare | 5.18% |
| 4 | Industrials | 4.16% |
| 5 | Consumer Discretionary | 3.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4101
ESS Tech
GWH
$18.1M
| $54.6K | ﹤0.01% |
5,028
-468
| -9% | -$6.38K |
|
4102
NIO
NIO
$11.6B
| $53.7K | ﹤0.01% |
11,933
-4,375
| -27% | -$26.4K |
|
4103
VerifyMe
VRME
$9.05M
| $52.1K | ﹤0.01% |
37,365
+21,344
| +133% | +$25K |
|
4104
Optical Cable Corp
OCC
$140M
| $50.9K | ﹤0.01% |
18,000
| – | – |
|
|
BIG
4105
DELISTED
Big Lots, Inc.
BIG
| $49.9K | ﹤0.01% |
11,526
-82,495
| -88% | -$436K |
|
4106
Heron Therapeutics
HRTX
$59.7M
| $49.9K | ﹤0.01% |
17,999
+4,576
| +34% | +$11.5K |
|
4107
Plug Power
PLUG
$3.08B
| $48.3K | ﹤0.01% |
14,046
+1,827
| +15% | +$6.79K |
|
|
TUYA
4108
Tuya Inc
TUYA
$1.11B
| $47.9K | ﹤0.01% |
27,385
| – | – |
|
4109
IAMGOLD
IAG
$10.4B
| $47K | ﹤0.01% |
14,125
-1,271
| -8% | -$3.39K |
|
4110
Peloton Interactive
PTON
$2.44B
| $46.3K | ﹤0.01% |
+10,816
| New | +$53.4K |
|
|
CRDL
4111
Cardiol Therapeutics
CRDL
$173M
| $45.7K | ﹤0.01% |
+25,380
| New | +$34.2K |
|
|
LUMO
4112
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $45.4K | ﹤0.01% |
16,115
+4,173
| +35% | +$12.4K |
|
4113
Clear Channel Outdoor Holdings
CCO
$1.23B
| $44K | ﹤0.01% |
26,668
+1,670
| +7% | +$2.85K |
|
4114
Douglas Elliman
DOUG
$179M
| $40.3K | ﹤0.01% |
25,518
-33,355
| -57% | -$68.3K |
|
4115
Adaptive Biotechnologies
ADPT
$4.1B
| $38.9K | ﹤0.01% |
12,120
-6,156
| -34% | -$23.8K |
|
|
NNDM
4116
Nano Dimension
NNDM
$349M
| $36.3K | ﹤0.01% |
13,033
-2,610
| -17% | -$6.72K |
|
4117
Denison Mines
DNN
$3B
| $36.2K | ﹤0.01% |
18,540
-4,711
| -20% | -$8.93K |
|
|
BZUN
4118
Baozun
BZUN
$170M
| $35.7K | ﹤0.01% |
+15,534
| New | +$37.2K |
|
|
AMTD
4119
AMTD IDEA Group
AMTD
$70.2M
| $35.7K | ﹤0.01% |
20,178
+3,044
| +18% | +$5.27K |
|
|
NAGE
4120
Niagen Bioscience
NAGE
$242M
| $34.8K | ﹤0.01% |
10,000
| – | – |
|
4121
Palladyne AI
PDYN
$307M
| $34.2K | ﹤0.01% |
+18,903
| New | +$19.3K |
|
|
OCFT
4122
DELISTED
OneConnect Financial Technology
OCFT
| $33.6K | ﹤0.01% |
15,139
+747
| +5% | +$1.82K |
|
4123
Emergent Biosolutions
EBS
$229M
| $33.3K | ﹤0.01% |
+13,153
| New | +$29.7K |
|
|
TVRD
4124
Tvardi Therapeutics
TVRD
$22.2M
| $32.6K | ﹤0.01% |
+994
| New | +$25.8K |
|
4125
Akebia Therapeutics
AKBA
$243M
| $30.2K | ﹤0.01% |
16,500
+2,500
| +18% | +$4K |
|
Similar funds
Envestnet Asset Management's Q1 2024 Portfolio in Review
As of Q1 2024, Envestnet Asset Management held 4,339 positions worth $268B, up 11% from $242B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Envestnet Asset Management deployed $9.25B of net new capital in Q1 2024, opening 297 new positions and adding to 2,310 existing holdings. Its largest new stake was BlackRock US Equity Factor Rotation ETF: 57,065,385 shares worth $2.53B.
By sector, the portfolio is most concentrated in Technology at 9.1% of assets, up from 8.7% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $2.01B trimmed.
- Envestnet Asset Management's largest Q1 2024 buy was BlackRock US Equity Factor Rotation ETF: 57,065,385 shares worth $2.53B.
- Envestnet Asset Management added most to iShares Core Universal USD Bond ETF in Q1 2024, an estimated $1.55B increase.
- Envestnet Asset Management's biggest Q1 2024 reduction was iShares Core S&P 500 ETF, cutting an estimated $2.01B.
- Envestnet Asset Management fully exited Splunk Inc in Q1 2024, selling an estimated $21.8M.
- Envestnet Asset Management's ten largest holdings make up 20% of its $268B portfolio in Q1 2024.
- Envestnet Asset Management opened 297 new positions and closed 169 in Q1 2024.
- Envestnet Asset Management's portfolio value rose 11% quarter-over-quarter to $268B.
Based on Envestnet Asset Management's 13F filing for Q1 2024, filed 13 May 2024.